Company Overview of DiObex, Inc.
DiObex, Inc. went out of business. DiObex, Inc. operates as a biotechnology company in the United States. The company develops novel products for the treatment of metabolic disorders, including type-one and type-two diabetes, dyslipidemia, obesity, and diabetic nephropathy. Its products include DIO-901, a very low dose glucagon product that is developed for the reduction of nocturnal hypoglycemia in patients with type-one diabetes; and DIO-902, a cortisol synthesis inhibitor that is developed as a therapy for glucose and cholesterol control in patients with type-two diabetes. DiObex, Inc. was founded in 2003 and is based in San Francisco, California.
600 Townsend Street
San Francisco, CA 94103
Founded in 2003
Key Executives for DiObex, Inc.
DiObex, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|Bioarray Therapeutics, Inc.||United States|
|Biota Technology, Inc.||United States|
|Precision Vascular Systems, Inc.||United States|
|Canyon Pharmaceuticals, Inc.||United States|
|BioVascular, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact DiObex, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.